X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2638) 2638
female (1813) 1813
carcinosarcoma - pathology (1805) 1805
middle aged (1419) 1419
aged (1379) 1379
carcinosarcoma (1316) 1316
male (1146) 1146
index medicus (807) 807
pathology (800) 800
oncology (686) 686
immunohistochemistry (675) 675
adult (655) 655
carcinosarcoma - surgery (553) 553
cancer (492) 492
aged, 80 and over (485) 485
prognosis (451) 451
uterine neoplasms - pathology (450) 450
tumors (448) 448
carcinoma (424) 424
obstetrics & gynecology (399) 399
carcinosarcoma - diagnosis (371) 371
neoplasm staging (352) 352
surgery (351) 351
diagnosis, differential (338) 338
uterus (325) 325
retrospective studies (283) 283
animals (273) 273
lung neoplasms - pathology (266) 266
carcinosarcoma - metabolism (245) 245
sarcoma (244) 244
adenocarcinoma - pathology (236) 236
sarcomatoid carcinoma (235) 235
carcinosarcoma - therapy (234) 234
carcinoma, squamous cell - pathology (225) 225
sarcoma - pathology (218) 218
carcinoma - pathology (215) 215
chemotherapy (215) 215
treatment outcome (203) 203
fatal outcome (195) 195
mixed mullerian tumors (181) 181
follow-up studies (177) 177
endometrial neoplasms - pathology (174) 174
urinary bladder neoplasms - pathology (171) 171
ovarian neoplasms - pathology (170) 170
carcinosarcoma - secondary (169) 169
combined modality therapy (168) 168
diagnosis (168) 168
esophageal neoplasms - pathology (168) 168
biomarkers, tumor - analysis (167) 167
expression (167) 167
adenocarcinoma (166) 166
tomography, x-ray computed (166) 166
carcinosarcoma - genetics (161) 161
carcinosarcoma - mortality (160) 160
carcinosarcoma - diagnostic imaging (156) 156
endometrial cancer (156) 156
survival rate (155) 155
carcinosarcoma - chemistry (154) 154
metastasis (149) 149
biopsy (146) 146
survival (145) 145
breast neoplasms - pathology (144) 144
gynecologic-oncology-group (142) 142
carcinosarcoma - drug therapy (141) 141
lymphatic metastasis (140) 140
neoplasm metastasis (140) 140
analysis (133) 133
mixed tumor, mullerian - pathology (131) 131
neoplasm invasiveness (126) 126
case report (125) 125
uterine carcinosarcoma (125) 125
medicine & public health (124) 124
rats (119) 119
hysterectomy (113) 113
differentiation (112) 112
uterine neoplasms - surgery (112) 112
biomarkers, tumor - metabolism (111) 111
chemotherapy, adjuvant (111) 111
antineoplastic combined chemotherapy protocols - therapeutic use (108) 108
care and treatment (107) 107
cell biology (106) 106
tumor (105) 105
disease-free survival (102) 102
neoplasms, multiple primary - pathology (100) 100
radiotherapy (99) 99
leiomyosarcoma (97) 97
skin neoplasms - pathology (96) 96
hematology, oncology and palliative medicine (95) 95
research (94) 94
uterine neoplasms - therapy (94) 94
of-the-literature (93) 93
uterine neoplasms - mortality (93) 93
neoplasms (92) 92
radiotherapy, adjuvant (92) 92
therapy (92) 92
leiomyosarcoma - pathology (91) 91
mutation (91) 91
keratins - analysis (89) 89
survival analysis (89) 89
prognostic-factors (88) 88
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2718) 2718
Japanese (98) 98
French (84) 84
German (82) 82
Chinese (44) 44
Russian (38) 38
Spanish (38) 38
Italian (34) 34
Polish (11) 11
Korean (6) 6
Hungarian (4) 4
Portuguese (4) 4
Turkish (4) 4
Bulgarian (3) 3
Czech (3) 3
Croatian (2) 2
Danish (2) 2
Romanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 135, Issue 2, pp. 223 - 230
Abstract Objectives Complete surgery with no macroscopic residual disease (RD) at primary (PDS) or interval debulking surgery (IDS) is the main objective of... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Neoadjuvant chemotherapy | Number of cycles | Interval surgery | Prognosis | Epithelial ovarian cancer | Number of cycles Prognosis | SURVIVAL | TRIALS | CYTOREDUCTIVE SURGERY | METAANALYSIS | SENSITIVITY | RESIDUAL DISEASE | OBSTETRICS & GYNECOLOGY | ONCOLOGY | ADVANCED-STAGE OVARIAN | RESISTANCE | PRIMARY DEBULKING SURGERY | CARCINOMA | Adenocarcinoma - pathology | Adenocarcinoma, Mucinous - pathology | Carcinosarcoma - surgery | Humans | Middle Aged | Ovarian Neoplasms - pathology | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - drug therapy | Cytoreduction Surgical Procedures | Young Adult | Carcinoma, Endometrioid - surgery | Adenocarcinoma, Mucinous - surgery | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Adenocarcinoma, Mucinous - drug therapy | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Neoplasms, Glandular and Epithelial - pathology | Reoperation | Treatment Outcome | Carcinoma, Endometrioid - drug therapy | Adenocarcinoma - drug therapy | Cystadenocarcinoma, Serous - surgery | Neoplasms, Glandular and Epithelial - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Adenocarcinoma, Clear Cell - pathology | Aged | Carcinosarcoma - drug therapy | Platinum Compounds - administration & dosage | Carcinoma, Endometrioid - pathology | Adenocarcinoma - surgery | Adenocarcinoma, Clear Cell - drug therapy | Cohort Studies | Ovarian Neoplasms - surgery | Cancer patients | Care and treatment | Surgery | Adjuvant treatment | Ovarian cancer | Cancer | Life Sciences
Journal Article
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, ISSN 0003-1488, 09/2019, Volume 255, Issue 6, pp. 669 - 672
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 3, pp. 384 - 392
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 05/2009, Volume 33, Issue 5, pp. 705 - 719
The authors present a series of 24 malignant neoplasms arising in preexisting benign spiradenoma, (20), cylindroma (2), and spiradenocylindroma (2). Nineteen... 
Cylindroma | Myoepithelial cells | Basal cell adenocarcinoma | Spiradenoma | Carcinosarcoma | Rhabdomyosarcoma | Brooke-Spiegler syndrome | Spiradenocylindroma | Salivary gland | Malignant | CYLD gene | TRANSFORMATION | SURGERY | carcinosarcoma | cylindroma | myoepithelial cells | CUTANEOUS CYLINDROMAS | spiradenoma | basal cell adenocarcinoma | PATHOLOGY | malignant | DERMAL CYLINDROMAS | TUMORS | salivary gland | ADNEXAL CARCINOMA | MULTIPLE FAMILIAL TRICHOEPITHELIOMA | spiradenocylindroma | ECCRINE SPIRADENOMA | SKIN | rhabdomyosarcoma | Carcinoma, Adenoid Cystic - therapy | Immunohistochemistry | Adenocarcinoma - pathology | Deubiquitinating Enzyme CYLD | Adenoma - genetics | Salivary Gland Neoplasms - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Carcinoma, Skin Appendage - pathology | Male | Sarcoma - therapy | Neoplasms, Multiple Primary - therapy | Adenoma - therapy | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Adult | Female | Cell Differentiation | Sarcoma - genetics | Carcinoma - pathology | Soft Tissue Neoplasms - genetics | Soft Tissue Neoplasms - therapy | Neoplasms, Multiple Primary - genetics | Carcinoma, Adenoid Cystic - pathology | Neoplasm Invasiveness | Europe | Treatment Outcome | Neoplasms, Multiple Primary - pathology | Sarcoma - pathology | Syndrome | Metaplasia | Carcinoma, Adenoid Cystic - genetics | Salivary Gland Neoplasms - therapy | Chromosomes, Human, Pair 16 | Soft Tissue Neoplasms - pathology | Adenoma - pathology | Carcinoma - genetics | Carcinoma - therapy | South Africa | Aged | Mutation | Australia | Salivary Gland Neoplasms - pathology
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2014, Volume 133, Issue 2, pp. 274 - 277
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2017, Volume 146, Issue 2, pp. 405 - 415
Abstract The emphasis in contemporary medical oncology has been “precision” or “personalized” medicine, terms that imply a strategy to improve efficacy through... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Pathology & clinical outcomes | Literature review | Sentinel lymph node mapping | Endometrial cancer | Surgical staging | Consensus recommendation | INDOCYANINE GREEN | MULTICENTER | RANDOMIZED CLINICAL-TRIAL | BIOPSY | BLUE-DYE | AXILLARY DISSECTION | DIAGNOSTIC-ACCURACY | OBSTETRICS & GYNECOLOGY | BREAST-CANCER | HYSTEROSCOPIC INJECTION | LYMPHADENECTOMY | ONCOLOGY | Lymph Node Excision | Neoplasms, Cystic, Mucinous, and Serous - surgery | Carcinosarcoma - surgery | Coloring Agents | Humans | Colorimetry | Carcinoma, Endometrioid - surgery | Societies, Medical | Spectroscopy, Near-Infrared | Female | Adenocarcinoma, Clear Cell - surgery | Carcinosarcoma - pathology | Organotechnetium Compounds | Neoplasms, Cystic, Mucinous, and Serous - pathology | Gynecology | Sentinel Lymph Node Biopsy - methods | Indocyanine Green | Single Photon Emission Computed Tomography Computed Tomography | Sentinel Lymph Node - pathology | Endometrial Neoplasms - surgery | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Neoplasm Staging | Surgical Oncology | Carcinoma, Endometrioid - pathology | Cancer | Endometrial Cancer | Pathology & Clinical Outcomes | Consensus Recommendation | Sentinel Lymph Node Mapping | Literature Review | Surgical Staging
Journal Article
Gastroenterology Clinics of North America, ISSN 0889-8553, 06/2017, Volume 46, Issue 2, pp. 365 - 391
Journal Article